HIV-1 down-modulates gamma signaling chain of Fc gamma R in human macrophages: a possible mechanism for inhibition of phagocytosis

J Immunol. 2002 Mar 15;168(6):2895-903. doi: 10.4049/jimmunol.168.6.2895.

Abstract

HIV-1 infection impairs a number of macrophage effector functions, thereby contributing to development of opportunistic infections and the pathogenesis of AIDS. FcgammaR-mediated phagocytosis by human monocyte-derived macrophages (MDM) is inhibited by HIV-1 infection in vitro, and the underlying mechanism was investigated in this study. Inhibition of phagocytosis directly correlated with the multiplicity of HIV-1 infection. Expression of surface FcgammaRs was unaffected by HIV-1 infection, suggesting that inhibition of phagocytosis occurred during or after receptor binding. HIV-1 infection of MDM markedly inhibited tyrosine phosphorylation of the cellular proteins, which occurs following engagement of FcgammaRs, suggesting a defect downstream of initial receptor activation. FcgammaR-mediated phagocytosis in HIV-infected MDM was associated with inhibition of phosphorylation of tyrosine kinases from two different families, Hck and Syk, defective formation of Syk complexes with other tyrosine-phosphorylated proteins, and inhibition of paxillin activation. Down-modulation of protein expression but not mRNA of the gamma signaling subunit of FcgammaR (a docking site for Syk) was observed in HIV-infected MDM. Infection of MDM with a construct of HIV-1 in which nef was replaced with the gene for the gamma signaling subunit augmented FcgammaR-mediated phagocytosis, suggesting that down-modulation of gamma-chain protein expression in HIV-infected MDM caused the defective FcgammaR-mediated signaling and impairment of phagocytosis. This study is the first to demonstrate a specific alteration in phagocytosis signal transduction pathway, which provides a mechanism for the observed impaired FcgammaR-mediated phagocytosis in HIV-infected macrophages and contributes to the understanding of how HIV-1 impairs cell-mediated immunity leading to HIV-1 disease progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Cyclic AMP / physiology
  • Cytoskeletal Proteins / antagonists & inhibitors
  • Cytoskeletal Proteins / metabolism
  • Down-Regulation / immunology*
  • Enzyme Precursors / antagonists & inhibitors
  • Enzyme Precursors / metabolism
  • HIV Infections / immunology
  • HIV Infections / metabolism
  • HIV-1 / immunology*
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Macrophages / immunology*
  • Macrophages / metabolism*
  • Macrophages / virology
  • Monocytes / immunology
  • Monocytes / metabolism
  • Monocytes / virology
  • Paxillin
  • Phagocytosis / immunology*
  • Phosphoproteins / antagonists & inhibitors
  • Phosphoproteins / metabolism
  • Phosphorylation
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / metabolism
  • Proto-Oncogene Proteins / antagonists & inhibitors
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-hck
  • Receptors, IgG / antagonists & inhibitors*
  • Receptors, IgG / biosynthesis
  • Receptors, IgG / physiology*
  • Signal Transduction / immunology*
  • Syk Kinase
  • Tyrosine / antagonists & inhibitors
  • Tyrosine / metabolism

Substances

  • Cytoskeletal Proteins
  • Enzyme Precursors
  • Intracellular Signaling Peptides and Proteins
  • PXN protein, human
  • Paxillin
  • Phosphoproteins
  • Proto-Oncogene Proteins
  • Receptors, IgG
  • Tyrosine
  • Cyclic AMP
  • Protein-Tyrosine Kinases
  • HCK protein, human
  • Proto-Oncogene Proteins c-hck
  • SYK protein, human
  • Syk Kinase